Erik Wendlandt

1.1k total citations
15 papers, 819 citations indexed

About

Erik Wendlandt is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Erik Wendlandt has authored 15 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in Erik Wendlandt's work include Multiple Myeloma Research and Treatments (8 papers), MicroRNA in disease regulation (4 papers) and Cancer Mechanisms and Therapy (2 papers). Erik Wendlandt is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), MicroRNA in disease regulation (4 papers) and Cancer Mechanisms and Therapy (2 papers). Erik Wendlandt collaborates with scholars based in United States, China and Mexico. Erik Wendlandt's co-authors include Anton P. McCaffrey, Rebecca T. Marquez, Kathy Keck, Fenghuang Zhan, Guido Tricot, Theresa L. Gioannini, Mary E. Wilson, Joel W. Graff, Sarmistha Bandyopadhyay and Michael Icardi and has published in prestigious journals such as Cancer Research, International Journal of Cancer and American Journal of Physiology-Gastrointestinal and Liver Physiology.

In The Last Decade

Erik Wendlandt

15 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Wendlandt United States	11	516	408	159	124	113	15	819
Ai Kotani Japan	19	541 1.0×	321 0.8×	70 0.4×	177 1.4×	347 3.1×	51	1.0k
Yuji Hori Japan	14	581 1.1×	114 0.3×	78 0.5×	138 1.1×	146 1.3×	31	925
Weilong Zhang China	12	482 0.9×	257 0.6×	30 0.2×	162 1.3×	37 0.3×	40	732
Fang Dong China	15	340 0.7×	187 0.5×	215 1.4×	168 1.4×	259 2.3×	62	778
Lucilla D’Abundo Italy	14	595 1.2×	536 1.3×	19 0.1×	84 0.7×	105 0.9×	21	813
Thomas S. K. Wan Hong Kong	19	630 1.2×	276 0.7×	194 1.2×	226 1.8×	70 0.6×	56	1.1k
Franco Izzo United States	14	526 1.0×	208 0.5×	84 0.5×	127 1.0×	67 0.6×	25	760
Udaya Yerramalla United States	8	315 0.6×	157 0.4×	25 0.2×	86 0.7×	64 0.6×	10	634
Liliana Terrin Italy	13	322 0.6×	95 0.2×	43 0.3×	202 1.6×	68 0.6×	21	707

Countries citing papers authored by Erik Wendlandt

Since Specialization

Citations

This map shows the geographic impact of Erik Wendlandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Wendlandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Wendlandt more than expected).

Fields of papers citing papers by Erik Wendlandt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Wendlandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Wendlandt. The network helps show where Erik Wendlandt may publish in the future.

Co-authorship network of co-authors of Erik Wendlandt

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Wendlandt. A scholar is included among the top collaborators of Erik Wendlandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Wendlandt. Erik Wendlandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Davis, Phillip, et al.. (2022). Development, testing and validation of a SARS-CoV-2 multiplex panel for detection of the five major variants of concern on a portable PCR platform. Frontiers in Public Health. 10. 1042647–1042647. 6 indexed citations

2.

Li, Can, Erik Wendlandt, Benjamin W. Darbro, et al.. (2021). Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and Progression. Cancers. 13(3). 517–517. 16 indexed citations

3.

Choi, Hyun Gyu, et al.. (2020). Anti-RDL and Anti-mGlutR1 Receptors Antibody Testing in Honeybee Brain Sections using CRISPR-Cas9. Journal of Visualized Experiments. 1 indexed citations

4.

Choi, Hyun Gyu, et al.. (2020). Anti-RDL and Anti-mGlutR1 Receptors Antibody Testing in Honeybee Brain Sections using CRISPR-Cas9. Journal of Visualized Experiments. 1 indexed citations

5.

Kelly, Kevin R., Claudia M. Espitia, Weiguo Zhao, et al.. (2015). Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus. Oncotarget. 6(38). 41275–41289. 44 indexed citations

6.

Yang, Ye, Jumei Shi, Zhimin Gu, et al.. (2015). Bruton Tyrosine Kinase Is a Therapeutic Target in Stem-like Cells from Multiple Myeloma. Cancer Research. 75(3). 594–604. 65 indexed citations

7.

Wendlandt, Erik, et al.. (2015). Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?. Oncotarget. 6(38). 40496–40506. 37 indexed citations

8.

Gu, Zhimin, Wen Zhou, Junwei Huang, et al.. (2014). Nek2 Is a Novel Regulator of B Cell Development and Immunological Response. BioMed Research International. 2014. 1–11. 22 indexed citations

9.

Hao, Mu, Meirong Zang, Erik Wendlandt, et al.. (2014). Low serum miR‐19a expression as a novel poor prognostic indicator in multiple myeloma. International Journal of Cancer. 136(8). 1835–1844. 58 indexed citations

10.

Salama, Mohamed E., Shouying Du, Olga Efimova, et al.. (2014). Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities. Leukemia & lymphoma. 56(2). 426–433. 3 indexed citations

11.

McCormick, Michael L., et al.. (2014). Copper–zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma. Redox Biology. 4. 23–33. 58 indexed citations

12.

Yang, Ye, Wen Zhou, Jiliang Xia, et al.. (2014). NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma. Oncotarget. 5(23). 11986–11997. 57 indexed citations

13.

Wendlandt, Erik, Joel W. Graff, Theresa L. Gioannini, Anton P. McCaffrey, & Mary E. Wilson. (2012). The role of MicroRNAs miR-200b and miR-200c in TLR4 signaling and NF-κB activation. Innate Immunity. 18(6). 846–855. 124 indexed citations

14.

Marquez, Rebecca T., Sarmistha Bandyopadhyay, Erik Wendlandt, et al.. (2010). Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Laboratory Investigation. 90(12). 1727–1736. 183 indexed citations

15.

Marquez, Rebecca T., et al.. (2010). MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targetsPellino-1, and inhibits NF-κB signaling. American Journal of Physiology-Gastrointestinal and Liver Physiology. 298(4). G535–G541. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact